ANVS earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -1.01. Updated 2026-07-23.
Annovis Bio (ANVS) Research Hub
Annovis Bio (ANVS) trades on NYSE, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.957 USD (-4.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.01, market cap 0.03B. This hub links to the full technical, earnings and options research available for ANVS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NYSE, US |
| Last close | 0.957 USD (-4.23%) |
| 52-week range | 0.9295 USD – 2.15 USD |
| Trend regime | Range |
| 14-day RSI | 27.9 (Oversold) |
| Trailing P/E | -1.01 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for ANVS
Covered Call on ANVS: how it works, illustrative setup around the real 0.957 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ANVS: how it works, illustrative setup around the real 0.957 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ANVS: how it works, illustrative setup around the real 0.957 USD price, max profit/loss, breakeven and when to use it. Educational.
ANVS technical analysis: range, last 0.957 USD, RSI 27.9, 52w range 0.9295 USD–2.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ANVS in?
Annovis Bio (ANVS) is classified under Healthcare (Biotechnology), listed on NYSE, US.
Is ANVS in an uptrend or downtrend?
As of 2026-10-26, ANVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ANVS's trailing P/E ratio?
ANVS's trailing P/E is -1.01, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does ANVS next report earnings?
ANVS is next scheduled to report earnings on 2026-08-11.